Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions
Example Bundle: Matilda Gravitate's IPS
id:
gravitate-Matilda
Composition status:
final
Composition Type:
Patient summary Document
Subject:
identifier:
Matilda-1
Name:
Matilda Gravitate
active:
true
gender:
female
Birth Date:
1950-09-01
Sections
Problem List
Condition:
Crohn's disease (34000006)
clinicalStatus:
active
asserter:
Dr. Ana Lopez
onsetDateTime:
2015
Medication Summary
Medication:
Humira 40 mg
status:
active
Medication Detail:
-
System
https://spor.ema.europa.eu/pmswi
Code:
EU/1/03/256/022 [Humira 40 mg]
-
System
https://www.who-umc.org/phpid
Code:
0xe72f98caa2b13cb3ccb489a1a7945c91 [Humira 40 mg solution for injection in pre-filled syringe 2 pre-filled syringes + 2 alcohol pads]
-
System
http://www.whocc.no/atc
Code:
L04AB04 [adalimumab]
Dose Form:
Solution for injection
Ingredient:
adalimumab (http://fdasis.nlm.nih.gov#FYS6T7F842)
strength:
40 mg/1
Route:
Subcutaneous use
Medication:
PARACETAMOL 1000 MG
status:
active
Medication Detail:
-
System
https://spor.ema.europa.eu/pmswi
Code:
72.741 [DOLOCATIL 1 g tablets]
-
System
https://www.who-umc.org/phpid
Code:
0xE857DA811B4A6F3BD57810C45D2EA1ED [Paracetamol 1g tablets]
-
System
http://www.whocc.no/atc
Code:
N02BE01 [paracetamol]
Dose Form:
Coated tablet
Ingredient:
ACETAMINOPHEN (http://fdasis.nlm.nih.gov#362O9ITL9D)
strength:
1000 mg/1 Tablet
Route:
Oral use
Medication:
Pentasa 1g mesalazine
status:
active
Medication Detail:
-
System
https://spor.ema.europa.eu/pmswi
Code:
77022 [Pentasa Slow Release Tablets 1g]
-
System
https://www.who-umc.org/phpid
Code:
0xF79CABF272B6A7EEF104DDDA44E827xx [Mesalazine, 1g, Tablets]
-
System
http://www.whocc.no/atc
Code:
A07EC02 [mesalazine]
Dose Form:
Tablet
Ingredient:
MESALAMINE (http://fdasis.nlm.nih.gov#4Q81I59GXC)
strength:
1000 mg/1 Tablet
Route:
Oral use